Titan Medical Inc
TSX:TMD

Watchlist Manager
Titan Medical Inc Logo
Titan Medical Inc
TSX:TMD
Watchlist
Price: 0.045 CAD 2 268.42% Market Closed
Market Cap: 1.1B CAD
Have any thoughts about
Titan Medical Inc?
Write Note

Titan Medical Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Titan Medical Inc
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Titan Medical Inc
TSX:TMD
Cash & Cash Equivalents
$3.9m
CAGR 3-Years
-59%
CAGR 5-Years
-18%
CAGR 10-Years
14%
Profound Medical Corp
TSX:PRN
Cash & Cash Equivalents
$34.1m
CAGR 3-Years
-23%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Opsens Inc
TSX:OPS
Cash & Cash Equivalents
CA$18.1m
CAGR 3-Years
77%
CAGR 5-Years
77%
CAGR 10-Years
39%
Nanalysis Scientific Corp
XTSX:NSCI
Cash & Cash Equivalents
CA$759k
CAGR 3-Years
-38%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Theralase Technologies Inc
XTSX:TLT
Cash & Cash Equivalents
CA$428.4k
CAGR 3-Years
-58%
CAGR 5-Years
-18%
CAGR 10-Years
-17%
MedMira Inc
XTSX:MIR
Cash & Cash Equivalents
CA$2.9m
CAGR 3-Years
725%
CAGR 5-Years
387%
CAGR 10-Years
26%
No Stocks Found

Titan Medical Inc
Glance View

Market Cap
1.1B CAD
Industry
Health Care

Titan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). The company is headquartered in Toronto, Ontario and currently employs 49 full-time employees. The company went IPO on 2008-04-28. The firm is developing its Enos system to become the new standard of care in robotic single access surgery, with dual three-dimensional (3D) and two-dimensional (2D) high-definition vision systems, multi-articulating instruments and an ergonomic surgeon workstation. Its multi-articulated instruments bring fluid to position the effectors for grasping, suturing, cutting and coagulation. The Enos surgeon workstation includes a 3D high-definition display to provide a balance of surgical immersion and situational awareness in the operating room.

TMD Intrinsic Value
0.003 CAD
Overvaluation 93%
Intrinsic Value
Price

See Also

What is Titan Medical Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
3.9m USD

Based on the financial report for Jun 30, 2024, Titan Medical Inc's Cash & Cash Equivalents amounts to 3.9m USD.

What is Titan Medical Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
14%

Over the last year, the Cash & Cash Equivalents growth was -63%. The average annual Cash & Cash Equivalents growth rates for Titan Medical Inc have been -59% over the past three years , -18% over the past five years , and 14% over the past ten years .

Back to Top